Does the evidence support population-wide screening for type 2 diabetes? No

Area of Science:

• Endocrinology
• Public Health
• Cardiovascular Medicine

Background:

• Undiagnosed type 2 diabetes poses significant mortality and morbidity risks.
• Centrally-coordinated screening is proposed to mitigate these risks.
• Evidence on the direct impact of such screening on major health outcomes is limited.

Purpose of the Study:

• To evaluate the direct consequences of centrally-coordinated type 2 diabetes screening programs.
• To assess the impact on cardiovascular disease and mortality.
• To analyze screening effectiveness in the context of opportunistic screening.

Main Methods:

• Analysis of data from a trial on centrally-coordinated type 2 diabetes screening.
• Comparison of outcomes between screened and control groups.
• Assessment of opportunistic screening prevalence within the control group.

Main Results:

• The centrally-coordinated screening program demonstrated minimal direct benefit on major health outcomes.
• High levels of opportunistic screening in the control group confounded the results.
• No clear advantage was observed for centrally-coordinated screening over existing opportunistic practices.

Conclusions:

• Centrally-coordinated screening for type 2 diabetes offers little additional benefit when opportunistic screening is prevalent.
• Current evidence does not support centrally-coordinated screening outside of usual healthcare settings in such contexts.
• Further research is needed to optimize diabetes screening strategies.